Company: SION
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0002036042-25-000016
Chunk: 200

Company: Sionna Therapeutics, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part II, Item 3
Chunk 200
---
 it by reference.

82

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIONNA THERAPEUTICS, INC.Date: May 12, 2025By:/s/Michael CloonanName:Michael Cloonan, M.B.A.Title:President and Chief Executive Officer(Principal Executive Officer)Date: May 12, 2025By:/s/Elena RidloffName:Elena Ridloff, C.F.A.Title:Chief Financial Officer and Head of Corporate Development(Principal Financial Officer and Principal Accounting Officer)

83